Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 850 mg Tablets Under Fed Conditions.

NCT07633028 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence Study in Healthy Subjects

Interventions

DRUG: Empagliflozin/metformin 12.5/850 mg tablet (test)
DRUG: Synjardy 12.5/850 mg tablet (Reference)

Sponsor

ADIUM